Clincosm LogoSign in Get a demo

Tuberculosis, Pulmonary

Showing 51 - 75 of 113
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis, Tuberculosis, Pulmonary Trial in San Antonio (TBI-223 50mg, Placebo for TBI-223 50mg, TBI-223 100, 300, 600, 1200,

Completed
  • Tuberculosis
  • Tuberculosis, Pulmonary
  • TBI-223 50mg
  • +9 more
  • San Antonio, Texas
    Worldwide Clinical Trials (WCT)
Sep 2, 2021

Bronchial Washings in Sputum Scarce Cases of Pulmonary

Withdrawn
  • Tuberculosis, Pulmonary
    • Karachi, Sindh, Pakistan
      Ojha Institute of Chest Diseases
    Aug 17, 2021

    Tuberculosis, Pulmonary Trial in Linköping (rifampicin, pyrazinamide, HRZE)

    Recruiting
    • Tuberculosis, Pulmonary
    • Linköping, Sweden
      Linköping University Hospital
    Aug 19, 2021

    Tuberculosis, Pulmonary, Households Trial in East London (Home-based point-of-care (POC) TB testing using GeneXpert device +

    Completed
    • Tuberculosis, Pulmonary
    • Households
    • Home-based point-of-care (POC) TB testing using GeneXpert device + MTB/RIF test
    • East London, Eastern Cape, South Africa
      Buffalo City Metro
    Jul 20, 2021

    Xpert MTB/XDR Clinical Evaluation Trial

    Completed
    • Tuberculosis, Pulmonary
    • Tuberculosis, Multidrug-Resistant
    • Cepheid Gene Xpert MTB/XDR
    • Chisinau, Moldova, Republic of
      Institute of Pthisiopenumology
    May 17, 2021

    Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis, Tuberculosis, Pulmonary Trial in Belarus, South

    Active, not recruiting
    • Tuberculosis, Multidrug-Resistant
    • +2 more
    • Minsk, Belarus
    • +6 more
    May 12, 2021

    Tuberculosis, Pulmonary Trial in Groningen (Sputum)

    Recruiting
    • Tuberculosis, Pulmonary
    • Sputum
    • Groningen, Netherlands
      University Medical Center Groningen
    Apr 30, 2021

    Tuberculosis, Pulmonary Trial in Kaohsiung, Taipei, Taoyuan City (4-month rifapentine-based regimen)

    Not yet recruiting
    • Tuberculosis, Pulmonary
    • 4-month rifapentine-based regimen
    • Kaohsiung, Taiwan
    • +3 more
    Apr 22, 2021

    Tuberculosis, Pulmonary Trial in Karachi (Bupropion, Behavioural Change Communication)

    Completed
    • Tuberculosis, Pulmonary
    • Karachi, Sindh, Pakistan
      Dow University of Health Sciences
    Apr 13, 2021

    Tuberculosis, Pulmonary, Physical Disability, Quality of Life Trial in Rio de Janeiro (Physical rehabilitation)

    Recruiting
    • Tuberculosis, Pulmonary
    • +2 more
    • Physical rehabilitation
    • Rio de Janeiro, RJ, Brazil
      University Hospital
    Apr 13, 2021

    Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Bacterial Infections Trial in Worldwide (Individualised treatment

    Recruiting
    • Tuberculosis, Pulmonary
    • +3 more
    • Individualised treatment duration based on RNA transcriptomic model
    • Borstel, Schleswig-Holstein, Germany
    • +4 more
    Apr 7, 2021

    Tuberculosis, Pulmonary, Tuberculosis, MDR, Tuberculosis Infection Trial in Tbilisi, Soweto, Klerksdorp (Control group, ASA

    Recruiting
    • Tuberculosis, Pulmonary
    • +2 more
    • Control group
    • +3 more
    • Tbilisi, Georgia
    • +2 more
    Apr 6, 2021

    Tuberculosis, Pulmonary Trial in China (Interleukin-2)

    Recruiting
    • Tuberculosis, Pulmonary
    • Fuyang, Anhui, China
    • +15 more
    Feb 20, 2021

    Tuberculosis, Pulmonary, Tuberculosis Trial in Ile Ife, Birmingham (Atorvastatin with standard anti tuberculosis drugs, Anti

    Unknown status
    • Tuberculosis, Pulmonary
    • Tuberculosis
    • Atorvastatin with standard anti tuberculosis drugs
    • Anti tuberculosis drugs only
    • Ile Ife, Osun, Nigeria
    • +1 more
    Feb 5, 2021

    Tuberculosis, Pulmonary Trial in Mbeya (N-acetyl cysteine)

    Recruiting
    • Tuberculosis, Pulmonary
    • N-acetyl cysteine
    • Mbeya, Tanzania
      NIMR-Mbeya Medical Research Centre
    Jan 18, 2021

    Respiratory Tract Infections, Tuberculosis, Pulmonary Trial in Worldwide (No Intervention, and Observational Study)

    Active, not recruiting
    • Respiratory Tract Infections
    • Tuberculosis, Pulmonary
    • No Intervention, and Observational Study
    • Fajara, Gambia
    • +3 more
    Jan 12, 2021

    Tuberculosis, Pulmonary Trial in Lausanne (PBTZ169, Placebo)

    Completed
    • Tuberculosis, Pulmonary
    • Lausanne, Vaud, Switzerland
      Division of Clinical Pharmacology, Centre Hospitalier Universita
    Oct 20, 2020

    Anti-tuberculosis Drugs in Gastrectomized Patients

    Completed
    • Tuberculosis
    • +2 more
    • standard first line anti-TB drugs
    • Goyang-si, Gyeonggi-do, Korea, Republic of
      Respiratory Clinic, National Cancer Center
    Sep 24, 2020

    Truenat Point-of-care Tuberculosis Diagnostic Test

    Completed
    • Tuberculosis, Pulmonary
    • Truenat MTB
    • Addis Ababa, Ethiopia
    • +3 more
    Aug 4, 2020

    Tuberculosis, Pulmonary Trial in Seoul (High-dose rifampicin, Isoniazid, Pyrazinamide)

    Not yet recruiting
    • Tuberculosis, Pulmonary
    • High-dose rifampicin
    • +4 more
    • Seoul, Korea, Republic of
      Division of Pulmonology and Critical Care Medicine, Department o
    Jul 21, 2020

    Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized

    Completed
    • Active Tuberculosis
    • +2 more
    • Nanodisk-MS assay
    • Sha Tin, Hong Kong
      Prince of Wales Hospital
    Feb 25, 2020

    Tuberculosis, Pulmonary Trial in Dhaka (double rimfampicin, Standard TB treatment)

    Completed
    Has Results
    • Tuberculosis, Pulmonary
    • double rimfampicin
    • Standard TB treatment
    • Dhaka, Greater Mymensingh District, Bangladesh
      Damien Foundation Bangladesh TB project in Greater Mymensingh di
    Feb 11, 2020

    Tuberculosis, Pulmonary Trial in Dhaka (6EH³RZ, 6EHR³Z, 6EHRZLfx)

    Withdrawn
    • Tuberculosis, Pulmonary
    • Dhaka, Bangladesh
      Damien Foundation
    Jan 16, 2020

    Tuberculosis, Hiv, Tuberculosis, Pulmonary Trial in Blantyre (Optimised HIV screening and linkage to care, Optimised

    Unknown status
    • Tuberculosis
    • +2 more
    • Optimised HIV screening and linkage to care
    • Optimised tuberculosis screening and linkage to care
    • Blantyre, Chichiri, Malawi
      Malawi-Liverpool-Wellcome Trust Clinical Research Programme
    Dec 6, 2019

    Efficacy and Safety of Intravenous Treatment of Tuberculosis

    Terminated
    • Tuberculosis, Pulmonary
    • Chernivtsi, Ukraine
    • +8 more
    Nov 4, 2019